Americord Registry

Americord Registry

Biotechnology, 225 Broadway, New York, 10007, United States, 11-50 Employees

americordblood.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 86********

Who is AMERICORD REGISTRY

Americord is a leader in the advancement of umbilical cord blood, cord tissue, and placental tissue banking. As a private bank, Americord collects, processes, and stores newborn stem cell...

Read More

map
  • 225 Broadway, New York, New York, 10007, United States Headquarters: 225 Broadway, New York, New York, 10007, United States
  • 2008 Date Founded: 2008
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8099 | NAICS Code: 621991 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AMERICORD REGISTRY

Americord Registry Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Americord Registry

Answer: Americord Registry's headquarters are located at 225 Broadway, New York, 10007, United States

Answer: Americord Registry's phone number is 86********

Answer: Americord Registry's official website is https://americordblood.com

Answer: Americord Registry's revenue is $25 Million to $50 Million

Answer: Americord Registry's SIC: 8099

Answer: Americord Registry's NAICS: 621991

Answer: Americord Registry has 11-50 employees

Answer: Americord Registry is in Biotechnology

Answer: Americord Registry contact info: Phone number: 86******** Website: https://americordblood.com

Answer: Americord is a leader in the advancement of umbilical cord blood, cord tissue, and placental tissue banking. As a private bank, Americord collects, processes, and stores newborn stem cells for future medical or therapeutic use by the family that saves them. Americord is committed to pioneering the development of new cord blood banking technologies. Under the direction of its Executive Medical Director, Dr. Robert Dracker, the company developed Cord Blood 2.0, a proprietary collection and extraction process that can harvest up to twice as many stem cells compared to a traditional cord blood collection. Based in New York, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Our Promises The highest quality stem cell preservation products and services in the industry A proven commitment to pioneering innovations that help families today and tomorrow The most value for your investment in cutting-edge medical options for your child and family

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access